PHE - Corporate - Screening for Lung Cancer and Tyrosinaemia
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the four UK countries on all matters relating to screening. The Committee is currently in the process of evaluating the cost effectiveness of screening for lung cancers in current and former smokers.
Buyer
Public Health England
Value
£48,869
Published
19 Jan 2021
Closes
31 Dec 2020
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Services
Contract starts
1 Jan 2021
Contract ends
30 Jun 2021
CPV classifications
75122000
Administrative healthcare services
Lots
Lot default PHE - Corporate - Screening for Lung Cancer and Tyrosinaemia
£48,869
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the four UK countries on all matters relating to screening. The Committee is currently in the process of evaluating the cost effectiveness of screening for lung cancers in current and former smokers.
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
19 Jan 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.